tiprankstipranks
Trending News
More News >

Mega Genomics Faces Delay in Annual Report and Trading Suspension

Story Highlights
Mega Genomics Faces Delay in Annual Report and Trading Suspension

Don’t Miss TipRanks’ Half-Year Sale

Mega Genomics Limited ( (HK:6667) ) just unveiled an update.

Mega Genomics Limited has announced a delay in the publication of its 2024 Annual Report, which was initially required to be dispatched by April 30, 2025, as per the Listing Rules of the Hong Kong Stock Exchange. This delay has also led to the continued suspension of trading of the company’s shares, which has been in effect since April 1, 2025. The company plans to announce the new dispatch date for the report and provide further updates as necessary, advising shareholders and potential investors to exercise caution.

More about Mega Genomics Limited

YTD Price Performance: -34.43%

Average Trading Volume: 108,169

Technical Sentiment Signal: Buy

Current Market Cap: HK$1.61B

Learn more about 6667 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1